GP scheme sees 700,000 scans completed

The General Practitioner Access to Community Diagnostics (GPACD) Scheme has seen a significant increase in demand, with over 700,000 radiology scans completed since its launch. The budget for the scheme has also increased to support its continued provision. The initiative allows GPs to refer patients directly for diagnostic scans such as X-ray, DXA, CT, and…

Read More

Syra Health partners with Indiana Department of Health

Healthcare technology company Syra Health, based in Indiana, has signed a one-year $480,000 contract with the Indiana Department of Health to assess the impact of public health risks on infrastructure and behavioral health in the state. The company provides population health tools, including health equity and epidemiology-focused solutions, and offers analytics on social determinants of…

Read More

Journalist Talks Distribution of Opioid Funds — And the Companies Angling for a Piece

Aneri Pattani, senior correspondent at KFF Health News, discussed how businesses are positioning themselves to access opioid settlement funds on “Marketplace” and how state and local governments are using the money on “The 21st Show.” She also wrote a series called “Payback: Tracking the Opioid Settlement Cash.” KFF Health News is a national newsroom that…

Read More

Tinengotinib exhibits activity in pretreated breast cancer

A study presented at the San Antonio Breast Cancer Symposium showed that the multikinase inhibitor Tinengotinib exhibited activity among heavily pretreated patients with hormone receptor-positive, HER2-negative breast cancer or those with triple-negative disease. The majority of patients in the study experienced treatment-related adverse events, but they were manageable. Efficacy results included objective responses and clinical…

Read More

Diagnostic accuracy high in emergency departments

A report published by the Agency for Healthcare Research and Quality found that diagnostic accuracy is generally high in emergency departments, with only about 5.7 percent of patients receiving an incorrect diagnosis. Out of these misdiagnosed patients, 2 percent suffered adverse events as a result, and 0.3 percent of these were serious. The report emphasizes…

Read More

COVID-19-associated blood plasma inflammatory factors do not affect blood-brain barrier, study shows

The coronavirus outbreak has resulted in a global health crisis, prompting researchers to investigate the potential impact of blood-brain barrier impairment on neurological problems during COVID-19 progression. The blood-brain barrier is a filtering mechanism for blood vessels carrying blood to the brain and spinal cord, preventing the passage of certain toxic substances. The study found…

Read More
error: Content is protected !!